PRIMA Chip Approved in the EU: A Step Toward Vision Restoration and a New Era for BCI

Science Corporation has received EU regulatory approval to market the PRIMA chip for vision restoration in patients with age-related macular degeneration.

Key points:
— the device is implanted in an outpatient procedure lasting about one hour;
— a camera in the glasses transmits images to the chip;
— the company says patients may achieve functional vision.

PRIMA has also received FDA designation, an initial step toward accelerated review in the United States.

Why it matters: technologies like this could restore essential everyday skills for people with vision loss and support a durable business model for future BCI development.

How do you assess the outlook for such implants?

#Biotech #MedTech #BCI #HealthTech